Skip to main content
. 2019 Feb;112(2):138–146. doi: 10.5935/abc.20180251

Figure 1.

Figure 1

Bar graph showing major cardiovascular adverse events, in the four groups based on aspirin and clopidogrel response. (A) Patients with adequate response to dual antiplatelet therapy; (B) patients with low response to aspirin; (C) patients with low response to clopidogrel; (D) patients with low response to dual antiplatelet therapy. MACE: major adverse cardiovascular events. compared with poor responders to dual antiplatelet therapy (OR:1.875 1.144-3.073, p < 0.001); ‡ compared with patients with poor response to clopidogrel (OR: 1.198, 0.957-1.499, p = 0.036).